Surgical outcomes of membrane-tube-type glaucoma shunt device in indigenous West Africans

Olusola Olawoye,1,2 Tarela Sarimiye,1,2 Adeyinka Ashaye,1,2 Young Hoon Hwang,3 Jong Chul Han,4 Byung Heon Ahn3 1Department of Ophthalmology, College of Medicine, University of Ibadan, 2Department of Ophthalmology, University College Hospital, Ibadan, Nigeria; 3Department of Ophthalmology, Konyang U...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Olawoye O, Sarimiye T, Ashaye A, Hwang YH, Han JC, Ahn BH
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://doaj.org/article/f5337df1df6349d8961589d12216e290
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f5337df1df6349d8961589d12216e290
record_format dspace
spelling oai:doaj.org-article:f5337df1df6349d8961589d12216e2902021-12-02T05:19:43ZSurgical outcomes of membrane-tube-type glaucoma shunt device in indigenous West Africans1177-5483https://doaj.org/article/f5337df1df6349d8961589d12216e2902018-02-01T00:00:00Zhttps://www.dovepress.com/surgical-outcomes-of-membrane-tube-type-glaucoma-shunt-device-in-indig-peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483Olusola Olawoye,1,2 Tarela Sarimiye,1,2 Adeyinka Ashaye,1,2 Young Hoon Hwang,3 Jong Chul Han,4 Byung Heon Ahn3 1Department of Ophthalmology, College of Medicine, University of Ibadan, 2Department of Ophthalmology, University College Hospital, Ibadan, Nigeria; 3Department of Ophthalmology, Konyang University, Kim’s Eye Hospital, Myung-Gok Eye Research Institute, 4Department of Ophthalmology, Samsung Medical Center, Sungkyunkwan University, School of Medicine, Seoul, South Korea Purpose: The aim of this study was to report the safety and efficacy of the membrane-tube (MT)-type glaucoma shunt device (Finetube MT) in the management of refractory glaucoma in indigenous West Africans.Methods: The Finetube MT was implanted into 25 eyes of 25 West African patients with refractory glaucoma. These patients had inadequate intraocular pressure (IOP) control despite maximum tolerable IOP-lowering medications with or without previous ocular surgeries. IOP, postoperative complications, interventions, visual acuities, and the number of IOP-lowering medications were analyzed preoperatively and postoperatively.Results: The mean (standard deviation [SD]) age of the patients was 49.7 (20.9) years. The mean (SD) follow-up duration was 21.0 (10.6) months. Postoperatively, the mean (SD) IOP reduced from a preoperative value of 38.1 (10.3) mmHg to 14.5 (4.6), 16.1 (7.8), and 14.7 (3.0) mmHg at 1, 2, and 3 years postoperatively, respectively, representing 61.9%, 57.7%, and 61.4% reduction from baseline (P<0.01). The mean (SD) number of IOP-lowering medications reduced from 4.1 (1.0) to 0.6 (0.9) at 1 year and 0.9 (1.1) at 2 years after the operation (P<0.01). Using an IOP level between 6 and 21 mmHg and reduced by ≥20% from baseline, the cumulative survival rate (standard error) was 96.0% (3.9%) at 6 months, 89.0% (6.0%) at 18 months, and 81.3% (10.6%) at 3 years after the operation. There was no postoperative ocular hypotony, tube occlusion, or device exposure.Conclusion: The Finetube MT may effectively control IOP with minimal risk of postoperative complications in indigenous West Africans. Keywords: glaucoma, intraocular pressure, glaucoma shunt device, West AfricaOlawoye OSarimiye TAshaye AHwang YHHan JCAhn BHDove Medical PressarticleGlaucomaIntraocular pressureSurgeryWest AfricansOphthalmologyRE1-994ENClinical Ophthalmology, Vol Volume 12, Pp 279-286 (2018)
institution DOAJ
collection DOAJ
language EN
topic Glaucoma
Intraocular pressure
Surgery
West Africans
Ophthalmology
RE1-994
spellingShingle Glaucoma
Intraocular pressure
Surgery
West Africans
Ophthalmology
RE1-994
Olawoye O
Sarimiye T
Ashaye A
Hwang YH
Han JC
Ahn BH
Surgical outcomes of membrane-tube-type glaucoma shunt device in indigenous West Africans
description Olusola Olawoye,1,2 Tarela Sarimiye,1,2 Adeyinka Ashaye,1,2 Young Hoon Hwang,3 Jong Chul Han,4 Byung Heon Ahn3 1Department of Ophthalmology, College of Medicine, University of Ibadan, 2Department of Ophthalmology, University College Hospital, Ibadan, Nigeria; 3Department of Ophthalmology, Konyang University, Kim’s Eye Hospital, Myung-Gok Eye Research Institute, 4Department of Ophthalmology, Samsung Medical Center, Sungkyunkwan University, School of Medicine, Seoul, South Korea Purpose: The aim of this study was to report the safety and efficacy of the membrane-tube (MT)-type glaucoma shunt device (Finetube MT) in the management of refractory glaucoma in indigenous West Africans.Methods: The Finetube MT was implanted into 25 eyes of 25 West African patients with refractory glaucoma. These patients had inadequate intraocular pressure (IOP) control despite maximum tolerable IOP-lowering medications with or without previous ocular surgeries. IOP, postoperative complications, interventions, visual acuities, and the number of IOP-lowering medications were analyzed preoperatively and postoperatively.Results: The mean (standard deviation [SD]) age of the patients was 49.7 (20.9) years. The mean (SD) follow-up duration was 21.0 (10.6) months. Postoperatively, the mean (SD) IOP reduced from a preoperative value of 38.1 (10.3) mmHg to 14.5 (4.6), 16.1 (7.8), and 14.7 (3.0) mmHg at 1, 2, and 3 years postoperatively, respectively, representing 61.9%, 57.7%, and 61.4% reduction from baseline (P<0.01). The mean (SD) number of IOP-lowering medications reduced from 4.1 (1.0) to 0.6 (0.9) at 1 year and 0.9 (1.1) at 2 years after the operation (P<0.01). Using an IOP level between 6 and 21 mmHg and reduced by ≥20% from baseline, the cumulative survival rate (standard error) was 96.0% (3.9%) at 6 months, 89.0% (6.0%) at 18 months, and 81.3% (10.6%) at 3 years after the operation. There was no postoperative ocular hypotony, tube occlusion, or device exposure.Conclusion: The Finetube MT may effectively control IOP with minimal risk of postoperative complications in indigenous West Africans. Keywords: glaucoma, intraocular pressure, glaucoma shunt device, West Africa
format article
author Olawoye O
Sarimiye T
Ashaye A
Hwang YH
Han JC
Ahn BH
author_facet Olawoye O
Sarimiye T
Ashaye A
Hwang YH
Han JC
Ahn BH
author_sort Olawoye O
title Surgical outcomes of membrane-tube-type glaucoma shunt device in indigenous West Africans
title_short Surgical outcomes of membrane-tube-type glaucoma shunt device in indigenous West Africans
title_full Surgical outcomes of membrane-tube-type glaucoma shunt device in indigenous West Africans
title_fullStr Surgical outcomes of membrane-tube-type glaucoma shunt device in indigenous West Africans
title_full_unstemmed Surgical outcomes of membrane-tube-type glaucoma shunt device in indigenous West Africans
title_sort surgical outcomes of membrane-tube-type glaucoma shunt device in indigenous west africans
publisher Dove Medical Press
publishDate 2018
url https://doaj.org/article/f5337df1df6349d8961589d12216e290
work_keys_str_mv AT olawoyeo surgicaloutcomesofmembranetubetypeglaucomashuntdeviceinindigenouswestafricans
AT sarimiyet surgicaloutcomesofmembranetubetypeglaucomashuntdeviceinindigenouswestafricans
AT ashayea surgicaloutcomesofmembranetubetypeglaucomashuntdeviceinindigenouswestafricans
AT hwangyh surgicaloutcomesofmembranetubetypeglaucomashuntdeviceinindigenouswestafricans
AT hanjc surgicaloutcomesofmembranetubetypeglaucomashuntdeviceinindigenouswestafricans
AT ahnbh surgicaloutcomesofmembranetubetypeglaucomashuntdeviceinindigenouswestafricans
_version_ 1718400507988410368